Brian J. Lynch - 23 Dec 2022 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
SVP and General Counsel
Signature
/s/ Brian J. Lynch
Issuer symbol
MDGL
Transactions as of
23 Dec 2022
Net transactions value
-$1,276,701
Form type
4
Filing time
28 Dec 2022, 19:00:22 UTC
Previous filing
12 Aug 2022
Next filing
06 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Options Exercise $642,530 +7,000 $91.79 7,000 23 Dec 2022 Direct F1
transaction MDGL Common Stock Sale $133,940 -500 -7.1% $267.88 6,500 23 Dec 2022 Direct F1, F3
transaction MDGL Common Stock Sale $80,697 -300 -4.6% $268.99 6,200 23 Dec 2022 Direct F1, F4
transaction MDGL Common Stock Sale $189,175 -700 -11% $270.25 5,500 23 Dec 2022 Direct F1, F5
transaction MDGL Common Stock Sale $217,016 -800 -15% $271.27 4,700 23 Dec 2022 Direct F1, F6
transaction MDGL Common Stock Sale $409,110 -1,500 -32% $272.74 3,200 23 Dec 2022 Direct F1, F7
transaction MDGL Common Stock Sale $147,406 -539 -17% $273.48 2,661 23 Dec 2022 Direct F1, F8
transaction MDGL Common Stock Sale $109,880 -400 -15% $274.70 2,261 23 Dec 2022 Direct F1, F9
transaction MDGL Common Stock Sale $27,524 -100 -4.4% $275.24 2,161 23 Dec 2022 Direct F1
transaction MDGL Common Stock Sale $27,640 -100 -4.6% $276.40 2,061 23 Dec 2022 Direct F1
transaction MDGL Common Stock Sale $100,275 -361 -18% $277.77 1,700 23 Dec 2022 Direct F1, F10
transaction MDGL Common Stock Sale $307,406 -1,100 -65% $279.46 600 23 Dec 2022 Direct F1, F11
transaction MDGL Common Stock Sale $56,082 -200 -33% $280.41 400 23 Dec 2022 Direct F1, F12
transaction MDGL Common Stock Sale $56,358 -200 -50% $281.79 200 23 Dec 2022 Direct F1, F13
transaction MDGL Common Stock Sale $56,722 -200 -100% $283.61 0 23 Dec 2022 Direct F1, F14
holding MDGL Common Stock 530 23 Dec 2022 In IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDGL Stock Option (Right to Buy) Options Exercise $0 -7,000 -22% $0.000000 25,000 23 Dec 2022 Common Stock 7,000 $91.79 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 All shares issued pursuant to the exercise of the options reported herein represent 7,000 shares underlying an overall option award of 32,000 shares. All exercised options had vested. As to the overall option for 32,000 shares, 25% of the shares underlying the option vested on March 5, 2021 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.32 to $268.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.64 to $269.54, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.72 to $270.69, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.87 to $271.85, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.18 to $273.14, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.19 to $273.95, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.24 to $275.04, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $277.51 to $278.13, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.00 to $279.95, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.17 to $280.66, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.45 to $282.14, inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.22 to 284.00, inclusive.